What divisions/businesses do you think Medtronic will sell-off/spin-off soon?

Discussion in 'Medtronic' started by anonymous, Apr 28, 2016 at 10:27 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Earl's out of the picture, so its not an emotional decision.....Omar will chop as he sees fit....
     

  2. anonymous

    anonymous Guest


    N.E.V.E.R.
     
  3. anonymous

    anonymous Guest


    Earl has his carmel popcorn line now to focus on. Any chance they will get back into the Obesity space?
     
  4. anonymous

    anonymous Guest

    SNS - Neuromodulation with single digit growth. NURO device launch is a total flop. Time to clean house.
     
  5. anonymous

    anonymous Guest

    Possibly Perfusion. Has already been established as a 'stand alone' business unit. Easier to 'unbundle' from MDT. Low margins, no growth. All that is needed is a willing buyer at the right price.
     
  6. anonymous

    anonymous Guest

    Kendall brands for sure and likely a Chinese buyer.
     
  7. anonymous

    anonymous Guest

    Latest on MITG spin off?
     
  8. anonymous

    anonymous Guest

    Just heard this week that Neuro/Pain is being considered for a sell-off to private equity group out of California. Could be interesting. What probably be the best thing as they may be motivated to innovate.
     
  9. anonymous

    anonymous Guest


    Can you provide any additional info?
     
  10. anonymous

    anonymous Guest

    Heard they were planning to sell off the super dimension division. Has anyone else heard that?
     
  11. anonymous

    anonymous Guest

    No...I'm not going to be tracked and locked up for violating insider trading laws. I do have details on proposed sizing: Very few sales layoffs expected (possibly increase in field force, in select markets). Minimum of $1.5million sales required per representative. Clinical specialists will be significantly downsized. Must have minimum of $2.5 million per territory to support sales and clinical. Exceptions will be made in markets where CS drives 50%+ sales (have no idea how that will be tracked). Will be an interesting late Summer/early-Fall.
     
  12. anonymous

    anonymous Guest

    Is this for kyphon?
     
  13. anonymous

    anonymous Guest

    Such BS!!! dumb***, learn the insider trading laws. You are a real life Gordon Gekko! BTW, the minimum territory size you are quoting have been in place for some time.
     
  14. anonymous

    anonymous Guest

    In place, but not readily enforced. That is where things will change, when we aren't protected under the large Spine sales. And no discussion of selling off Kyphon, but will be reabsorbed in the spine rep bag
     
  15. anonymous

    anonymous Guest

    Why would they do that? Do you know the main call point for the Kyphon team? It is Interventional radiology. The spine reps do not have a clue on how to work in this area.